John Hilkens

7.9k citations

92 papers · 6.3k indexed · h-index 40

Impact in

Immunology top 1%
- Galectins and Cancer Biology
- Immunotherapy and Immune Responses
Radiology, Nuclear Medicine and Imaging top 0.5%
- Monoclonal and Polyclonal Antibodies Research

Papers in

Immunology and Allergy 9
- Cell Adhesion Molecules Research 9
Immunology 31
- Galectins and Cancer Biology 16
- Immunotherapy and Immune Responses 6

Co-authors: Hans L. Vos F Buijs Jelle Wesseling Marjolijn J. L. Ligtenberg Arnoud Sonnenberg M J Ligtenberg Sergey V. Litvinov S. V. Litvinov
Journals: International Journal of Cancer (7 papers)Journal of Biological Chemistry (6 papers)Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin (3 papers)Tumor Biology (3 papers)Breast Cancer Research (2 papers)
Partner nations: Netherlands United Kingdom United States

In The Last Decade

John Hilkens

91 papers receiving 6.1k citations

Peers

Countries citing papers authored by John Hilkens

Since Specialization

Citations

This map shows the geographic impact of John Hilkens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Hilkens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Hilkens more than expected).

Fields of papers citing papers by John Hilkens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Hilkens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Hilkens. The network helps show where John Hilkens may publish in the future.

Co-authorship network

The 25 scholars most cited alongside John Hilkens, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John Hilkens Line = papers co-authored together John Hilkens links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Insertional mutagenesis in a HER2-positive breast cancer model reveals ERAS as a driver of cancer and therapy resistance Oncogene ·Nokele Sonayena Kenneth, Mandy Boer, Elvira R. M. Bakker, D. DeBeer, Basanta Pathak, Jelle ten Hoeve, Jos Jonkers, Lodewyk F.A. Wessels, John Hilkens	2018	8
2	MUC1-ARF—A Novel MUC1 Protein That Resides in the Nucleus and Is Expressed by Alternate Reading Frame Translation of MUC1 mRNA PLoS ONE ·大輔葛目, K.C. Chao, Edward Pichinuk, Christian Garbar, Armand Bensussan, Alan K. Meeker, Ravit Ziv, کمال طاهر موسى محمد, Nechama I. Smorodinsky, John Hilkens, Franz‐Georg Hanisch, Daniel B. Rubinstein, Daniel H. Wreschner	2016	10
3	MUC1 extracellular domain confers resistance of epithelial cancer cells to anoikis Cell Death and Disease ·Qingbai Zhao, William Hughes, Shasha Cui, Michael A. Hollingsworth, John Hilkens, Jonathan M. Rhodes, Lu‐Gang Yu	2014	29
4	Analysis of Tumor Heterogeneity and Cancer Gene Networks Using Deep Sequencing of MMTV-Induced Mouse Mammary Tumors PLoS ONE ·Christiaan Klijn, Marco J. Koudijs, Jaap Kool, Jelle ten Hoeve, Mandy Boer, P D Purwanti, Waseem Akhtar, L.F. Manuel, D. DeBeer, Marcel Reinders, David J. Adams, Maarten van Lohuizen, John Hilkens, Lodewyk F.A. Wessels, Jos Jonkers	2013	18
5	Interaction between circulating galectin-3 and cancer-associated MUC1 enhances tumour cell homotypic aggregation and prevents anoikis Molecular Cancer ·Qicheng Zhao, Nislene de Matos Moraes, John Hilkens, Xiuli Guo, Hannah Barrow, Jonathan M. Rhodes, Lu‐Gang Yu	2010	177
6	Circulating Galectin-3 Promotes Metastasis by Modifying MUC1 Localization on Cancer Cell Surface Cancer Research ·Qicheng Zhao, Xiuli Guo, Gerard B. Nash, Philip C. Stone, John Hilkens, Jonathan M. Rhodes, Lu‐Gang Yu	2009	138
7	MMTV insertional mutagenesis identifies genes, gene families and pathways involved in mammary cancer Nature Genetics ·Vassiliki Theodorou, Yi Yao, Mandy Boer, Lodewyk F.A. Wessels, Wendy Theelen, Jos Jonkers, John Hilkens	2007	143
8	Galectin-3 Interaction with Thomsen-Friedenreich Disaccharide on Cancer-associated MUC1 Causes Increased Cancer Cell Endothelial Adhesion Journal of Biological Chemistry ·Lu‐Gang Yu, R Lawrynowicz, Qicheng Zhao, Horatio Bot, Muhammad Riza Pahlawi, J. Vuylsteke, Oleg V. Gerasimenko, John Hilkens, Jun Hirabayashi, Ken‐ichi Kasai, Jonathan M. Rhodes	2006	248
9	Fgf10 is an oncogene activated by MMTV insertional mutagenesis in mouse mammary tumors and overexpressed in a subset of human breast carcinomas Oncogene ·Vassiliki Theodorou, Mandy Boer, Britta Weigelt, Jos Jonkers, Martin van der Valk, John Hilkens	2004	53
10	Tumor-Host Interactions Regulate Glucocorticoid-Mediated Epiglycanin Expression in TA3Ha Murine Mammary Carcinoma Cells Tumor Biology ·R. Nawrocki, John Hilkens	2003	2
11	Altered expression and allelic association of the hypervariable membrane mucin MUC1 in gastritis UCL Discovery (University College London) ·Lynne E. Vinall, M. Bruce King, Juan Zarate-Yepez, 赵娜如, (unknown), John Hilkens, M. Sarner, Dallas M. Swallow	2002	0
12	Monoclonal Antibodies against the Nonmucin Domain of MUC1/Episialin Tumor Biology ·John Hilkens, Mandy Boer	1998	12
13	A mechanism for inhibition of E-cadherin-mediated cell-cell adhesion by the membrane-associated mucin episialin/MUC1. Molecular Biology of the Cell ·Jelle Wesseling, Maxime Bertauts, John Hilkens	1996	340
14	Immunoscintigraphy of small-cell lung cancer xenografts with anti neural cell adhesion molecule monoclonal antibody, 123C3: improvement of tumour uptake by internalisation British Journal of Cancer ·Carmy Carranza, Jelle Wesseling, Shen Lanfeng, Nico van Zandwijk, John Hilkens	1996	11
15	Is episialin/MUC1 involved in breast cancer progression? Cancer Letters ·John Hilkens, Hans L. Vos, Jelle Wesseling, Mandy Boer, Janet Storm, M Swamikannu, Jero Calafat, Carlo Patriarca	1995	70
16	NCAM and lung cancer International Journal of Cancer ·Rob Michalides, E. K. Grebel, D.R. Springall, Nico van Zandwijk, J. Koopman, John Hilkens, Wolter J. Mooi	1994	51
17	Episialin (MUC1) inhibits cytotoxic lymphocyte-target cell interaction. The Journal of Immunology ·E. van de Wiel-van Kemenade, M J Ligtenberg, Annemiek J. de Boer, F Buijs, Hans L. Vos, Cornelis J.M. Melief, John Hilkens, Carl G. Figdor	1993	192
18	Molecular cloning and localization to chromosome 6 of mouseINT1L1 gene Somatic Cell and Molecular Genetics ·Andrew M. Chan, John Hilkens, V. Kroezen, Philip J. Mitchell, Peter Scambler, Brandon J. Wainwright, R. Williamson, Colin S. Cooper	1989	6
19	A mouse homeobox containing gene on chromosome 11: sequence and tissue-specific expression Nucleic Acids Research ·Frits Meijlink, Miao Yan, Peter Verrijzer, Olivier Destrée, V. Kroezen, John Hilkens, Jacqueline Deschamps	1987	53
20	Localization of a gene for expression of mouse mammary tumor virus antigens in the GR/Mtv-2- mouse strain. The Journal of Experimental Medicine ·Roel Nusse, P D Purwanti, John Hilkens, R. Van Nie	1980	29

About John Hilkens

John Hilkens is a scholar working on Immunology and Allergy, Immunology, Radiology, Nuclear Medicine and Imaging, Molecular Biology and Oncology, having authored 92 papers that have together received 6.3k indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (45 papers), Monoclonal and Polyclonal Antibodies Research (24 papers), Galectins and Cancer Biology (16 papers), Cell Adhesion Molecules Research (9 papers), Virus-based gene therapy research (7 papers), Immunotherapy and Immune Responses (6 papers), Cancer Cells and Metastasis (5 papers) and RNA and protein synthesis mechanisms (5 papers). The work is most often cited by research in Immunology (2.3k citations), Radiology, Nuclear Medicine and Imaging (1.6k citations), Molecular Biology (4.6k citations), Immunology and Allergy (387 citations) and Oncology (1.4k citations). John Hilkens has collaborated with scholars based in Netherlands, United Kingdom and United States. Frequent co-authors include Hans L. Vos, F Buijs, Jelle Wesseling, Marjolijn J. L. Ligtenberg, Arnoud Sonnenberg, M J Ligtenberg, Sergey V. Litvinov, S. V. Litvinov, Annemiek M.C. Gennissen and Lu‐Gang Yu. Their work appears in journals such as International Journal of Cancer, Journal of Biological Chemistry, Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin, Tumor Biology and Breast Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact